CN1111133A - No.1 antiphlogistic and anti-neoplastic powder - Google Patents
No.1 antiphlogistic and anti-neoplastic powder Download PDFInfo
- Publication number
- CN1111133A CN1111133A CN 93114060 CN93114060A CN1111133A CN 1111133 A CN1111133 A CN 1111133A CN 93114060 CN93114060 CN 93114060 CN 93114060 A CN93114060 A CN 93114060A CN 1111133 A CN1111133 A CN 1111133A
- Authority
- CN
- China
- Prior art keywords
- neoplastic
- powder
- antiphlogistic
- lingkucao
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The No.1 antiphlogistic and anti-neoplastic powder mainly contains bezoar, notoginseng, etc. It has the functions of antipyresis, detoxication, invigorating blood circulation, dispersing blood clots, anodyne, anticarcinogen, etc. and clinical use shows its effective rate of 96.5% and curative rate of 90.2% to inflammation, tumour and cancer of mammary gland, adnexa uteri, neck lymph node, prostate gland and thyroid gland.
Description
The invention belongs to the Chinese medicine technical field, is No. 1, a kind of middle medicine-" antiphlogistic and anti-neoplastic powder powder " that is mainly used in inflammation such as treatment mammary gland, adnexa, lymphonodi cervicales, prostate, tumor, cancer.
The tcm methods of diseases such as existing treatment mammary gland, adnexa, prostate is to adopt " newborn low disappears ", " lump disappears ", " asparagine ", " FUYANLING ", " QIANLIEKANG ", " Phenoxybenzamine " respectively, cervical adenopathy does not have the Chinese medicine specific drug, through clinical application total effective rate 30-60%, the no clinical cancer cure rate of controlling, not only effective percentage is low, and function singleness, related diseases can not dialectical double controlling.
The objective of the invention is to develop a kind of Chinese medicine that can treat surgery inflammation such as mammary gland, adnexa, lymphonodi cervicales, prostate, thyroid, tumor, cancer, has heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, dispersing swelling and dissipating binds, analgesic hemostatic, sterilization, anticancer, preventing cancer function, treatment effective percentage and cure rate increase.
The present invention's " antiphlogistic and anti-neoplastic powder powder " mainly contains Calculus Bovis, Radix Notoginseng, Pseudobulbus Cremastrae Seu Pleiones, Lingkucao medicinal preparation No. 1, is equipped with Radix Ranunculi Ternati, Herba Taraxaci, Herba Violae, is prepared from.Lingkucao medicinal preparation is a kind of new drug.
No. 1 medicine source of the present invention's " antiphlogistic and anti-neoplastic powder powder " is wide, and consumption is little, and expenses for medicine is cheap, bitter in the mouth is cold in nature, has heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, dispersing swelling and dissipating binds, the sterilization analgesic hemostatic, functions such as cancer-resisting are through clinic trial 1227 examples, for inflammation, benign tumor, malignant neoplastic diseases such as treatment mastitis, cystic hyperplasia of breast, cyclomastopathy, tuberculosis of breast and gynecological's adnexa, lymphonodi cervicales, prostate, thyroid significant curative effect is arranged all, have no side effect total effective rate 96.5%, cure rate 90.2%.
One of No. 1 prescription example formulations of the present invention's " antiphlogistic and anti-neoplastic powder powder ", Calculus Bovis 1%, Radix Notoginseng 25%, Pseudobulbus Cremastrae Seu Pleiones 10%, Radix Ranunculi Ternati 15%, Lingkucao medicinal preparation 35%, Herba Taraxaci 7%, Herba Violae 7%.
Two of example formulations, Calculus Bovis 2%, Radix Notoginseng 25%, Radix Ranunculi Ternati 7%, Pseudobulbus Cremastrae Seu Pleiones 7%, Lingkucao medicinal preparation 29%, Herba Taraxaci 15%, Herba Violae 15%.
Three of example formulations, Calculus Bovis 1%, Radix Notoginseng 35%, Radix Ranunculi Ternati 7%, Pseudobulbus Cremastrae Seu Pleiones 8%, Lingkucao medicinal preparation 35%, Herba Taraxaci 7%, Herba Violae 7%.
Four of example formulations, Calculus Bovis 2%, Radix Notoginseng 30%, Radix Ranunculi Ternati 10%, Pseudobulbus Cremastrae Seu Pleiones 15%, Lingkucao medicinal preparation 25%, Herba Taraxaci 10%, Herba Violae 8%.
Through effective produce effects 985 examples of clinical 1028 routine mammary gland carcinoma (wherein male's 9 examples) on probation, total effective rate 95.8%, cure 876 examples, account for 85.2%, produce effects 109 examples account for 10.6%, as the case patient recklessly * *, the woman, 50 years old, the Henan Province * worker of county water conservancy bureau, about 7 * 8 centimetres of two swelling of the breast tumors, matter is hard, district hospital was diagnosed as breast carcinoma through ground, and clothes " newborn low disappears ", " lump disappears ", " asparagine " more than 20 bottle of effect is bad, through clothes antiphlogistic and anti-neoplastic powder powder of the present invention No. 11 month, tumor matter is soft, totally two recoveries from illness course of treatment in 2 months.
Through clinical treatment lymphadenopathy 103 routine effective percentage 100%, cure 99 examples and account for 97%, treatment prostatosis 96 examples, effective percentage 100% is cured 93 examples, accounts for 97.2%.
Claims (2)
1, No. 1, a kind of Chinese medicine antiphlogistic and anti-neoplastic powder powder, it is characterized in that mainly containing Calculus Bovis, Pseudobulbus Cremastrae Seu Pleiones, Lingkucao medicinal preparation, Radix Notoginseng;
2,, it is characterized in that in above-mentioned prescription, being added with Radix Ranunculi Ternati, Herba Taraxaci, Herba Violae according to the Chinese medicine of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93114060 CN1111133A (en) | 1993-10-31 | 1993-10-31 | No.1 antiphlogistic and anti-neoplastic powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93114060 CN1111133A (en) | 1993-10-31 | 1993-10-31 | No.1 antiphlogistic and anti-neoplastic powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1111133A true CN1111133A (en) | 1995-11-08 |
Family
ID=4990371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93114060 Pending CN1111133A (en) | 1993-10-31 | 1993-10-31 | No.1 antiphlogistic and anti-neoplastic powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1111133A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100446782C (en) * | 2005-10-27 | 2008-12-31 | 上海中医大源创科技有限公司 | Traditional Chinese medicine gels for treating acute gout arthritis |
-
1993
- 1993-10-31 CN CN 93114060 patent/CN1111133A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100446782C (en) * | 2005-10-27 | 2008-12-31 | 上海中医大源创科技有限公司 | Traditional Chinese medicine gels for treating acute gout arthritis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105597063A (en) | Health-care type hot-compress Chinese medicine bag and preparation method thereof | |
| CN101904977B (en) | Medicament for treating mastitis and preparation method thereof | |
| CN105535508A (en) | Radix astragali and sanguis draxonis bedsore healing unguent and preparation method | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN101744977B (en) | External plaster for treating breast diseases and preparation method thereof | |
| CN1111133A (en) | No.1 antiphlogistic and anti-neoplastic powder | |
| CN104706919B (en) | A kind of pharmaceutical composition for the treatment of ulcer in body surface | |
| CN102335369A (en) | Traditional Chinese medicinal adhesive plaster for treating mammary gland hyperplasia | |
| CN100546640C (en) | A kind of Chinese medicine composition of orally taken for curing cyclomastopathy | |
| CN103083387A (en) | Congestion-eliminating pain-relieving plaster | |
| CN1136909C (en) | Liniment 'Rubikang' and its preparing process | |
| CN1326753A (en) | Musk skin growing ointment | |
| CN106692878A (en) | Medicine for treating mammary gland hyperplasia and preparation method of medicine | |
| CN101703733B (en) | Medicament for treating tumor-like diseases | |
| CN1101693C (en) | Externally applied Chinese medicine | |
| CN101301412B (en) | Capsules for soothing depression and dissipating binds | |
| CN104857262A (en) | Pure Chinese material medicine preparation for treating knife wounds and postoperative pyogenic infection | |
| CN1152464A (en) | Health care tea for anti-tumour | |
| CN106729370A (en) | A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation | |
| CN1055839C (en) | Pill for treatment of cancer and its preparing process | |
| CN108686163A (en) | A kind of externally applied Chinese medicine wax moxibustion for treating mammary gland disease | |
| CN1170592A (en) | External application medicinal bag for curing cancerbus ache and incision ache after operation and its preparing method | |
| CN1383878A (en) | Chinese herbal medicine recipe for treating gastric cancer | |
| CN114699451A (en) | Mixture for treating hemorrhoids and fistula | |
| CN1066067C (en) | Belt for regulating qi, activating collateral and protecting liver |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |